Anteris Technologies Global (AVR) Metrics: History & Chart

Anteris Technologies Global Corp.(AVR)

Medical - Devices · Eagan, MN

$7.55-0.16 (-2.08%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Eagan, MN

174 employees

anteristech.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Wayne Geoffrey Paterson

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-2.45%
30D Total Return	-16.48%
YTD Total Return	+51.30%
1Y Total Return	+75.17%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+51.30%
2025	-10.57%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+74.71%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

AVR Valuation Metrics

AVR Stock Price Metrics

AVR Dividend Metrics

AVR Growth Rate Metrics

AVR Discounted Cash Flow Metrics

AVR Returns By Period

AVR Yearly Returns

AVR Average Annual Returns By Period (CAGR)

AVR Revenue Metrics

AVR PE Ratio Metrics

AVR PS Ratio Metrics

AVR PB Ratio Metrics

AVR Price to Free Cash Flow Ratio Metrics

AVR Debt to Equity Ratio Metrics

AVR PEG Ratio Metrics

AVR FCF Yield

AVR Earnings Yield

AVR EBITDA Yield

AVR OCF Yield

AVR EV/EBIT Ratio Metrics

AVR EV/EBITDA Ratio Metrics

AVR EV/Assets Ratio Metrics

AVR EV/Sales Ratio Metrics

AVR Current Ratio Metrics

AVR Quick Ratio Metrics

AVR ROIC Metrics

AVR Return on Assets Metrics

AVR Return on Equity Metrics

AVR Net Profit Margin Metrics

AVR Gross Profit Margin Metrics

AVR Tax Rate Metrics

PS Ratio	327.80
PS Ratio Avg TTM	191.08
PS Ratio Avg 3Y	57.35
Current VS TTM Avg	+71.55%
Current VS 3Y Avg	+471.60%
Current VS 5Y Avg	+471.60%

PB Ratio	2.92
PB Ratio Avg TTM	13.71
PB Ratio Avg 3Y	16.08
Current VS TTM Avg	-78.70%
Current VS 3Y Avg	-81.84%
Current VS 5Y Avg	-81.84%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	(4.75)
Debt/Equity Ratio Avg 3Y	0.26
Current VS TTM Avg	+100.28%
Current VS 3Y Avg	-94.95%
Current VS 5Y Avg	-94.48%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.76
Ev/Assets Ratio Avg TTM	3.80
Ev/Assets Ratio Avg 3Y	3.87
Current VS TTM Avg	-53.67%
Current VS 3Y Avg	-54.52%
Current VS 5Y Avg	-54.52%

Ev/Sales Ratio	214.48
Ev/Sales Ratio Avg TTM	133.47
Ev/Sales Ratio Avg 3Y	50.62
Current VS TTM Avg	+60.70%
Current VS 3Y Avg	+323.68%
Current VS 5Y Avg	+323.68%

Current Ratio	14.20
Current Ratio Avg TTM	7.82
Current Ratio Avg 3Y	1.88
Current VS TTM Avg	+81.48%
Current VS 3Y Avg	+654.87%
Current VS 5Y Avg	+522.02%

Quick Ratio	14.20
Quick Ratio Avg TTM	7.81
Quick Ratio Avg 3Y	1.85
Current VS TTM Avg	+81.85%
Current VS 3Y Avg	+668.84%
Current VS 5Y Avg	+535.37%

ROIC	(41.63%)
ROIC Avg 3Y	(1047.05%)
ROIC Avg 5Y	(1047.05%)
Current VS 3Y Avg	+96.02%
Current VS 5Y Avg	+96.02%
Current VS 10Y Avg	+96.02%

ROA	(38.01%)
ROA Avg TTM	(62.87%)
ROA Avg 3Y	(60.35%)
Current VS TTM Avg	+39.54%
Current VS 3Y Avg	+37.02%
Current VS 5Y Avg	+8.54%

ROE	(41.20%)
ROE Avg TTM	(139.78%)
ROE Avg 3Y	(161.84%)
Current VS TTM Avg	+70.52%
Current VS 3Y Avg	+74.54%
Current VS 5Y Avg	+74.54%

Net Profit Margin	(4619.67%)
Net Profit Margin Avg TTM	(5104.27%)
Net Profit Margin Avg 3Y	(3111.83%)
Current VS TTM Avg	+9.49%
Current VS 3Y Avg	-48.46%
Current VS 5Y Avg	-129.00%

Gross Profit Margin	(16.57%)
Gross Pft Margin Avg TTM	29.71%
Gross Pft Margin Avg 3Y	34.79%
Current VS TTM Avg	-155.77%
Current VS 3Y Avg	-147.63%
Current VS 5Y Avg	-163.86%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A